BiotechTube

CT-P16 + Avastin

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Adenocarcinoma of Lung

Conditions

Adenocarcinoma of Lung

Trial Timeline

Feb 1, 2019 → Sep 19, 2023

NCT ID
NCT03676192

About CT-P16 + Avastin

CT-P16 + Avastin is a phase 3 stage product being developed by Celltrion for Adenocarcinoma of Lung. The current trial status is completed. This product is registered under clinical trial identifier NCT03676192. Target conditions include Adenocarcinoma of Lung.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03676192Phase 3Completed

Competing Products

20 competing products in Adenocarcinoma of Lung

See all competitors
ProductCompanyStageHype Score
Autologous Mesothelin-specific TCR-T Cells + Cyclophosphamide + Fludarabine + BendamustineLonzaPhase 1
30
[203Pb]Pb-PSV359 + [212Pb]Pb-PSV359Perspective TherapeuticsPhase 1/2
33
Zentalis + GemzarZentalis PharmaceuticalsPhase 2
44
ACR-368 + GemcitabineAcrivon TherapeuticsPhase 2
44
RamucirumabEli LillyPhase 1/2
41
Ramucirumab + Paclitaxel + PlaceboEli LillyPhase 3
77
BA3182BioAtlaPhase 1
25
Ramucirumab (IMC-1121B ) + PaclitaxelEli LillyPhase 1
33
Bevacizumab + Capecitabine + Cisplatin + Placebo + 5-fluorouracilChugai PharmaceuticalPhase 3
77
Trastuzumab DeruxtecanDaiichi SankyoPhase 2
52
Trastuzumab deruxtecan + Ramucirumab + PaclitaxelDaiichi SankyoPhase 3
77
Trastuzumab Deruxtecan (T-DXd) monotherapy + T-DXd, Durvalumab and Capecitabine CombinationDaiichi SankyoPhase 2
52
Trastuzumab deruxtecanDaiichi SankyoPhase 2
52
DS-8201aDaiichi SankyoPhase 1
33
Trastuzumab deruxtecan + 5FU/LV + Trastuzumab deruxtecan + FLODaiichi SankyoPhase 1/2
41
EnzalutamideAstellas PharmaPhase 2
52
zolbetuximabAstellas PharmaPre-clinical
23
zolbetuximab + placebo + oxaliplatin + folinic acid + fluorouracilAstellas PharmaPhase 3
77
zolbetuximabAstellas PharmaPre-clinical
23
epirubicin + oxaliplatin + capecitabine + zolbetuximabAstellas PharmaPhase 2
52

Other Products from Celltrion

Azathioprine + PlaceboApproved
85
Infliximab CT-P13 + Immunosuppressors (Thiopurines or Methotrexate)Approved
85
Infliximab + Infliximab + InfliximabApproved
85
Pioglitazone + Alogliptin + Alogliptin + Metformin + DapagliflozinApproved
85
Pioglitazone 15 MG [Actos] + Empagliflozin 10 MG [Jardiance] + Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos]Approved
85